Market Place
Sourcing Support
All News #Library
Biotech
Atavistik Bio Secures $40M Series B Extension, Totaling $160M
05 Mar 2026 //
GLOBENEWSWIRE
Atavistik Bio Secures $120M For Allosteric Therapeutics In (HHT)
18 Dec 2025 //
GLOBENEWSWIRE
Atavistik Bio To Unveil JAK2 V617F Mutant-Selective Inhibitors
04 Dec 2025 //
GLOBENEWSWIRE
Atavistik Bio Appoints Susan Pandya as Chief Medical Officer
15 Sep 2025 //
GLOBENEWSWIRE
Atavistik Bio Doses First Patient in Phase 1 Trial of ATV-1601
04 Aug 2025 //
GLOBENEWSWIRE
Atavistik Bio Presents Preclinical Data on ATV-1601 at EORTC
23 Oct 2024 //
GLOBENEWSWIRE
Atavistik Bio Nominates ATV-1601 As Precision Oncology Candidate
15 Oct 2024 //
GLOBENEWSWIRE
Atavistik Bio Appoints Mohammad Hirmand To Board
25 Sep 2024 //
GLOBENEWSWIRE
Atavistik Bio Appoints Paul Bruno As Chief Business Officer
12 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.